DJO Eyes More Acquisitions for Joint Replacement Growth

DJO's logo

DJO reported 3Q20 orthopedic revenue of USD $130.8 million, +6.4% vs. 3Q19. Colfax leadership sees the market as 90% to 95% recovery and expects healthy growth rates over 2019 levels to return in 2021. DJO’s joint replacement business grew in the high single digits, indicating that it is taking share in a quarter when some larger competitors...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us